Get started
Author

Tatiana P. Grazioso

Observed names: Grazioso, Tatiana P., T. Grazioso, T.P. Grazioso, Tatiana P Grazioso
ORCID: 0009-0005-3592-9850
Observed ORCID: 0009-0005-3592-9850
OpenAlex ID: A5078948613
mTORC1 Inactivation Promotes Colitis-Induced Colorectal Cancer but Protects from APC Loss-Dependent Tumorigenesis
2017 · Marta Brandt, Tatiana P. Grazioso, et al. · Cell Metabolism · 54
PDF
Diet, Microbiota, and Colorectal Cancer
2019 · Tatiana P. Grazioso, Marta Brandt, et al. · iScience · 37
Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer
2024 · Miguel Quiralte, Arantzazu Barquín, et al. · Journal of Clinical Investigation · 31
PDF
Multicenter study correlating molecular characteristics and clinical outcomes of cancer cases with patient-derived organoids
2025 · Paloma Navarro, Tatiana P. Grazioso, et al. · Journal of Experimental & Clinical Cancer Research · 15
PDF
The forgotten art of cold therapeutic properties in cancer: A comprehensive historical guide
2023 · Tatiana P. Grazioso, Nabil Djouder · iScience · 10
PDF
A mechanistic view of the use of cold temperature in the treatment of cancer
2023 · Tatiana P. Grazioso, Nabil Djouder · iScience · 5
Phase II clinical trial assessing the efficacy of enzalutamide in advanced non-resectable granulosa cell ovarian tumors: The GREKO III study (GETHI2016–01)
2024 · Jesus García-Donas, Andres Redondo, et al. · Gynecologic Oncology · 4
Detection of chromosome instability by interphase FISH in mouse and human tissues
2021 · Raul Torres-Ruiz, Tatiana P. Grazioso, et al. · STAR Protocols · 4
PDF
Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: the Greko II study (GETHI2013-01)
2024 · Jesus Garcia-Donas, Laia Garrigos, et al. · Clinical & Translational Oncology · 3
Cold exposure reinstates NAD + levels and attenuates hepatocellular carcinoma
2024 · Tatiana P Grazioso, Maria del Mar Rigual, et al. · Cell Stress · 2
Retrospective study assessing the role of the androgen receptor in clear cell renal cell cancer patients treated with VEGFR inhibitors in monotherapy
2024 · Lucia Osorio, Tatiana P. Grazioso, et al. · Clinical & Translational Oncology · 2
Prospective study of the real impact of fusion centered genomic assays in patient management in a national collaborative group: the GETHI-XX-16 study
2024 · Paloma Navarro, Carmen Beato, et al. · Clinical & Translational Oncology · 1
175eP Association of BRCA mutation type and functional domain with progression-free survival in ovarian cancer: A real-world observational study
2026 · B. Campos Vives, J.M. San Miguel Barros, et al. · ESMO Open
PDF
135P Elucidating immune and tumor microenvironment dynamics in ovarian cancer
2026 · T.P. Grazioso, J.M. San Miguel Barros, et al. · ESMO Open
PDF
Selective bladder-sparing trial with sasanlimab as maintenance treatment based on clinical response to neoadjuvant treatment in molecularly categorized muscle invasive bladder cancer patients: SASAN-SPARING trial.
2026 · Elena Sevillano, Tatiana P. Grazioso, et al. · Journal of Clinical Oncology
SASAN-SPARING: A phase 2 trial of sasanlimab maintenance as bladder-sparing option after neoadjuvant chemotherapy in patients with muscle invasive bladder cancer.
2026 · Elena Sevillano, Tatiana P. Grazioso, et al. · Journal of Clinical Oncology
A0163 – Establishment of primary prostate cancer patient-derived organoids to assess the molecular mechanisms underlying prostate carcinogenesis and antitumor drug response
2025 · J. Justo Quintas, T.P. Grazioso, et al. · European Urology
Testicular cancer epidemiology in Spain
2025 · Juan Francisco Rodríguez Moreno, Blanca Campos Vives, et al. · Revisiones en cáncer
PDF
181P Establishment of primary prostate cancer patient-derived organoids to assess PARP inhibitors antitumor activity beyond synthetic lethality
2024 · T.P. Grazioso, R. Otta, et al. · ESMO Open
PDF
Patient derived renal cell carcinoma organoids and isolated autologous tumor infiltrating lymphocytes as cancer in vitro models for immunotherapy agents screening
2024 · V. Hevia Palacios, J. García-Donas, et al. · European Urology
Works count: 22
Citation count: 168
H-index: 5
I10-index: 5
Year
Topic
Type